BD
BRENT DEL MONTE
BGR GOVERNMENT AFFAIRS · Washington, DC · registered since 2024
Registered · LDAActive
At a glance
Registered since
2024
Senate LDA system
Clients
29
last 3 years
Filings
90
10 agencies contacted
Activity
filings by quarter
Works on
Background
Government experience
Leg. Dir. Rep. Bliley; Sen. Counsel House Energy & Commerce Committee
Disclosed on LD-2 filings
See prior filing
Disclosed on LD-2 filings
Career
BG
Specific issues
Provide strategic counsel and advocate on issues related to Type 1 Diabetes policy
Provide strategic counsel and advocate on issues related to diagnostic testing issues generally and bioMerieux specifically.
Provide strategic counsel and advocate on issues related to rare disease drug development
Provide strategic counsel and advocacy on issues relating to biopharmaceuticals for rare diseases driven by genetic causes generally, or BioMarin Pharmaceutical specifically.
Provide strategic counsel and advocacy for issues related to policies impacting the pharmaceutical industry generally including drug shortages, patient out of pocket costs, supply chain, PBM policies, kidney care policies, Inflation Reduction Act (IRA) implementation issues, the Maintaining Investments in New Innovation (MINI) Act S. 476/H.R.5547, and biopharma innovation policies.
Provide strategic guidance and advocacy regarding legislation and regulations related to research and treatment of ALS
Clients
Filing history
EDWARDS LIFESCIENCES LLC
GLAXOSMITHKLINE, INC
EVERYONE MEDICINES
PFIZER, INC
NATIONAL RESILIENCE, INC.
ABIOMED INC
BIOMARIN PHARMACEUTICAL INC.
ESSILORLUXOTTICA (FKA ESSILOR OF AMERICA, INC.)
WALGREEN CO.
AMEDISYS, INC.
BIOTECHNOLOGY INNOVATION ORGANIZATION
PTC THERAPEUTICS